Recommendations for the treatment of hepatitis C in 2017

Area of Science:

• Hepatology
• Infectious Diseases
• Clinical Guidelines

Background:

• Chronic Hepatitis C virus (HCV) infection necessitates treatment to prevent severe liver damage and transmission.
• Current guidelines recommend treatment for most patients, with specific prioritization for those at high risk of poor outcomes.

Purpose of the Study:

• To provide comprehensive recommendations for the management of chronic HCV infection.
• To guide optimal medication selection, fibrosis assessment, and treatment monitoring.
• To address special patient populations and treatment-resistant cases.

Main Methods:

• Review and synthesis of current evidence and expert opinion.
• Development of guidelines for patient selection, treatment strategies, and monitoring.
• Inclusion of recommendations for specific genotypes and patient subgroups.

Main Results:

• All patients with chronic HCV infection should receive treatment, except those with a very short life expectancy.
• Priority is given to patients with liver cirrhosis, advanced fibrosis, extrahepatic manifestations, kidney disease, or transplant recipients.
• Guidelines cover medication selection, fibrosis assessment, resistance management, HCC surveillance, and special populations.

Conclusions:

• Effective management of HCV infection requires tailored treatment strategies based on patient risk and disease characteristics.
• These recommendations aim to optimize treatment outcomes, reduce disease progression, and prevent transmission.
• Adherence to guidelines ensures appropriate care for diverse patient groups, including those with coinfections or treatment failure.